The World Bank Board of Directors approved a USD 500 million loan today to strengthen Peru's Vaccination Plan by purchasing 40 million COVID-19 vaccines to vaccinate 20 million people (62 percent of the population), including adults who have not completed their vaccination schedule and minors. The vaccines will be delivered in the first half of 2022 by Pfizer and Moderna laboratories.

COVID-19 has had a serious impact on the health and livelihoods of the Peruvian people, as well as the country's economy. The pandemic has also put the country's significant social and economic gains of the last two decades in jeopardy, exacerbating poverty and inequality. To deal with the consequences of this crisis, the country must step up efforts to close vaccination gaps.

Peru has made significant progress toward vaccinating the entire population by 2021. In just seven months, the country's fully vaccinated population increased from 2 percent  in May to 69.7 percent  in mid-December. The shift to a territorial strategy was critical for increasing vaccination rates. To date, over 19.5 million people have received two doses, while 22.8 million have received one dose.

With this operation, the World Bank continues to support Peru's response to the pandemic's social and economic consequences. The World Bank has committed nearly $1 billion in contingent and policy programme support financing for economic reactivation in 2020 and 2021.

Afghanistan receives 3rd batch of World Bank's cash assistance

US Senate to vote on Joe Biden's social spending bill early next year

Joe Biden admin calls for to unfreeze Afghan central bank reserves